{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:49:24Z","timestamp":1772851764869,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Leefmilieu Brussel","award":["SUB\/BEA\/2015\/VUB"],"award-info":[{"award-number":["SUB\/BEA\/2015\/VUB"]}]},{"name":"\u2018Chair Mireille Aerens for Alternative Methods Development\u2019"},{"name":"Fund for Scientific Research in Flanders","award":["G030217N"],"award-info":[{"award-number":["G030217N"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.toxlet.2017.11.014","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T03:37:50Z","timestamp":1513309070000},"page":"184-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone"],"prefix":"10.1016","volume":"284","author":[{"given":"Alessandra","family":"Natale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Boeckmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Desmae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"De Boe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joery","family":"De Kock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Rogiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robim M.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2017.11.014_bib0005","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"Fed. Eur. Biochem. Soc."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/pr.108.00001","article-title":"Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis","volume":"60","author":"Anderson","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0015","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep.24290","article-title":"Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in heparg cells","volume":"53","author":"Anth\u00e9rieu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/kfl184","article-title":"Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells","volume":"96","author":"Atienzar","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0025","article-title":"Letter to the Editor","volume":"325","author":"Berridge","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0030","series-title":"New Technologies for Toxicity Testing","author":"Bouvier d\u2019Yvoire","year":"2012"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0040","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"C\u00e9sar-Razquin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0045","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0192623309352496","article-title":"A strategy for risk management of drug-induced phospholipidosis","volume":"37","author":"Chatman","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfh100","article-title":"Use and application of stem cells in toxicology","volume":"79","author":"Davila","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0055","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1089\/scd.2011.0723","article-title":"Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential","volume":"21","author":"De Kock","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0060","first-page":"115","article-title":"Fatty acid regulation of hepatic lipid metabolism","volume":"14","author":"Donald","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0065","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2174\/138920012802850001","article-title":"Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates","volume":"13","author":"Donato","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0070","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00204-016-1845-1","article-title":"Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man","volume":"90","author":"Dragovic","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0075","series-title":"Introduction to Lipids and Lipoproteins","author":"Feingold","year":"2015"},{"issue":"Suppl. 1","key":"10.1016\/j.toxlet.2017.11.014_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-8278(97)82328-8","article-title":"Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation","volume":"26","author":"Fromenty","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cmet.2012.03.007","article-title":"The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling","volume":"15","author":"Fu","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2214\/ajr.144.3.541","article-title":"Increased hepatic density and phospholipidosis due to amiodarone","volume":"144","author":"Goldman","year":"1985","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0095","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4155\/bio.09.128","article-title":"Mechanisms of amine accumulation in, and egress from, lysosomes","volume":"1","author":"Goldman","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.1840080514","article-title":"Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease","volume":"8","author":"Guigui","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/460208a","article-title":"Toxicology for the twenty-first century","volume":"460","author":"Hartung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0115","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1258\/ebm.2011.011128","article-title":"The emerging roles of fatty acid translocase\/CD36 and the aryl hydrocarbon receptor in fatty liver disease","volume":"236","author":"He","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00498250310001657568","article-title":"Phase I and II enzyme characterization of two sources of HepG2 cell lines","volume":"34","author":"Hewitt","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0125","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1128\/MCB.00627-06","article-title":"Lysosomal phospholipase A2 and phospholipidosis","volume":"26","author":"Hiraoka","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0006-2952(81)90451-2","article-title":"Studies on the mechanism of drug-induced lipidosis","volume":"30","author":"Hoestetler","year":"1981","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/SCCAA.S16417","article-title":"Stem cells A model for screening, discovery and development of drugs","volume":"4","author":"Kitambi","year":"2011","journal-title":"Stem Cells Cloning Adv. Appl."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0140","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"L\u00fcllmann","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.2009.03381.x","article-title":"Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity","volume":"67","author":"Lafuente-Lafuente","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10408444.2012.682115","article-title":"Organotypic liver culture models: meeting current challenges in toxicity testing","volume":"42","author":"LeCluyse","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0046-8177(90)90076-H","article-title":"Histopathologic analysis of suspected amiodarone hepatotoxicity","volume":"21","author":"Lewis","year":"1990","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/geno.1999.5940","article-title":"The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression","volume":"62","author":"Li","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfm157","article-title":"In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid \u2013 based methodologies","volume":"99","author":"Nioi","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1293\/tox.21.9","article-title":"Drug-induced phospholipidosis \u2013 pathological aspects and its prediction","volume":"21","author":"Nonoyama","year":"2008","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tiv.2014.12.012","article-title":"In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatments","volume":"30","author":"Pomponio","year":"2015","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0180","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-008X(89)90054-9","article-title":"A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs","volume":"97","author":"Reasor","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00204-014-1199-5","article-title":"Human stem cell \u2013 derived hepatocytes: breakthrough of an expedient tool for preclinical assessment of drug \u2013 induced liver injury?","author":"Rodrigues","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/scd.2013.0157","article-title":"Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals","volume":"23","author":"Rodrigues","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0200","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.tiv.2014.10.012","article-title":"Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors","volume":"29","author":"Rodrigues","year":"2015","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00204-015-1483-z","article-title":"In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells","volume":"90","author":"Rodrigues","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/bbrc.2001.5375","article-title":"Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis","volume":"286","author":"Sakakura","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5604\/16652681.1171749","article-title":"Drug-induced fatty liver disease: an overview of pathogenesis and management","volume":"14","author":"Satapathy","year":"2015","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0220","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system","volume":"83","author":"Sawada","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0225","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bbalip.2006.07.011","article-title":"The phospholipase A2 superfamily and its group numbering system","volume":"1761","author":"Schaloske","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0230","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0022-2275(20)41642-6","article-title":"Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids","volume":"32","author":"Schmitz","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0235","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tiv.2005.01.003","article-title":"Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake","volume":"19","author":"Schoonen","year":"2005","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0240","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbalip.2012.08.013","article-title":"Drug induced phospholipidosis: an acquired lysosomal storage disorder","volume":"1831","author":"Shayman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxlet.2017.11.014_bib0245","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/toxsci\/kfq361","article-title":"Phospholipidosis induced by PPAR gamma signaling in human bronchial epithelial (BEAS-2B) cells exposed to amiodarone","volume":"120","author":"Song","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0250","first-page":"727","article-title":"Isolation and characterization of multipotent skin-derived precursors from human skin","volume":"23","author":"Toma","year":"2005","journal-title":"Adv. Environ. Biol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1021653506123","article-title":"Identification of HepG2 variant cell lines by short tandem repeat (STR) analysis","volume":"243","author":"van Pelt","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0260","doi-asserted-by":"crossref","first-page":"23742","DOI":"10.1074\/jbc.M102348200","article-title":"ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0265","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/17425255.2017.1341489","article-title":"Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury","volume":"13","author":"Weaver","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.toxlet.2017.11.014_bib0270","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1091\/mbc.10.3.537","article-title":"High-affinity binding of the AP-1 adaptor complex to trans-golgi network membranes devoid of mannose 6-phosphate receptors","volume":"10","author":"Zhu","year":"1999","journal-title":"Mol. Biol. Cell"}],"updated-by":[{"DOI":"10.1016\/j.toxlet.2020.09.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000}}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842741731473X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842741731473X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T16:37:59Z","timestamp":1660149479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037842741731473X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":54,"alternative-id":["S037842741731473X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.11.014","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.toxlet.2020.09.014","asserted-by":"object"}]},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}